EDT.TO Stock - Spectral Medical Inc.
Unlock GoAI Insights for EDT.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.29M | $1.60M | $1.67M | $2.00M | $2.10M |
| Gross Profit | $1.02M | $662,000 | $983,000 | $1.16M | $1.47M |
| Gross Margin | 44.5% | 41.4% | 59.0% | 58.3% | 70.1% |
| Operating Income | $-11,997,000 | $-11,421,000 | $-8,447,000 | $-6,657,000 | $-8,941,000 |
| Net Income | $-15,402,000 | $-15,662,000 | $-11,281,000 | $-8,785,000 | $-9,098,000 |
| Net Margin | -673.8% | -980.1% | -676.7% | -440.1% | -433.0% |
| EPS | $-0.05 | $-0.06 | $-0.04 | $-0.03 | $-0.04 |
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
EDT.TOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q4 2025 | Nov 7, 2025 | $-0.02 | $-0.11 | -428.2% | ✗ MISS |
Q3 2025 | Aug 8, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 9, 2025 | — | $-0.04 | — | — |
Q1 2025 | Mar 27, 2025 | — | $0.01 | — | — |
Q4 2024 | Nov 8, 2024 | — | $-0.04 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-0.02 | — | — |
Q2 2024 | May 13, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 28, 2024 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.01 | $-0.01 | 0.0% | = MET |
Q3 2023 | Aug 10, 2023 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2023 | May 12, 2023 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2023 | Mar 24, 2023 | $-0.01 | $-0.01 | -30.0% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-0.01 | $-0.01 | -20.0% | ✗ MISS |
Q3 2022 | Aug 12, 2022 | $-0.01 | $-0.01 | -10.0% | ✗ MISS |
Q2 2022 | May 13, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2022 | Mar 24, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q4 2021 | Nov 12, 2021 | $-0.01 | $-0.01 | -20.0% | ✗ MISS |
Q3 2021 | Aug 13, 2021 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2021 | May 14, 2021 | $-0.01 | $-0.01 | -30.0% | ✗ MISS |
Latest News
Frequently Asked Questions about EDT.TO
What is EDT.TO's current stock price?
What is the analyst price target for EDT.TO?
What sector is Spectral Medical Inc. in?
What is EDT.TO's market cap?
Does EDT.TO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to EDT.TO for comparison